• <em>BRAF</em> mutation in myeloid neoplasm: incidences and clinical outcomes
• <em>De-Novo</em> B-Cell Prolymphocytic Leukemia
• A 95-year-old patient suffered high-grade B-cell lymphoma combined hairy cell leukemia
• A Case of Hairy Cell Leukemia Variant: Literature Analysis With Focus on Unmet Needs
• A case report of early diagnosis of asymptomatic hairy cell leukemia using flow cytometry
• A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAF^V600E in cancer cells
• A Rare Clinical Case of Secondary Central Nervous System Involvement without Transformation in Hairy Cell Leukemia: A Case Report and Literature Review
• A Rare Clinical Case of Secondary Central Nervous System Involvement without Transformation in Hairy Cell Leukemia: Case Report and Literature Review
• A rare finding of plasma cell leukaemia with hairy-cell morphology
• Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genes
• Atraumatic Splenic Rupture as an Unusual Presentation of Hairy Cell Leukemia: A Case Report
• Atraumatic splenic rupture as first presentation of hairy cell leukaemia-a case report
• Atypical meningeal localization of classical hairy cell leukemia with an impressive response to rituximab and cladribine association. A case report and literature review
• BCL2 Inhibition in Refractory Hairy-Cell Leukemia
• Beyond the norm: unusual orbital manifestation of hairy cell leukemia
• Biclonal Low-Grade B Cell Lymphoma as Detected by Multiparametric Flow Cytometry in Blood and Marrow
• BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes
• Broadening the horizon: potential applications of CAR-T cells beyond current indications
• Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization
• Chinese guideline for diagnosis and treatment of hairy cell leukemia (2023)
• Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency
• Clinical analysis of hairy cell leukemia: the rare indolent hematological malignancy
• Concomitantly Diagnosed Disseminated M kansasii Infection and Hairy Cell Leukemia With Review of Pathophysiology
• COVID-19 in patients with classic and variant hairy cell leukemia
• De-Novo B-Cell Prolymphocytic Leukemia
• Detangling the Threads of Hairy Cell Leukemia, Beyond the Morphology and Into the Molecular
• Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies
• Diagnosis of chronic B-cell lymphoproliferative disease in peripheral blood = how machine learning may help to the interpretation of flow cytometry data
• Drug-induced secondary haemophagocytic lymphohistiocytosis in hairy cell leukaemia
• Early clearance of hairy cell leukaemia in the bone marrow after first-line treatment with cladribine predicts a favourable outcome
• Editorial: Novel targeted drugs for indolent lymphoid malignancies
• Editorial: Tumour microenvironment heterogeneity in hematological malignancies
• Enhancing Efficacy and Quality of Life in Patients with Herpes Zoster Infection in Hairy Cell Leukemia
• Expanding the Benefit: Dabrafenib/Trametinib as Tissue-Agnostic Therapy for <em>BRAF</em> V600E-Positive Adult and Pediatric Solid Tumors
• Extramedullary Paravertebral Mass: An Unusual Presentation of Hairy Cell Leukaemia
• Flow Cytometry of CD5-Positive Hairy Cell Leukemia
• Hairy cell leukaemia with an IGH-BRAF fusion gene
• Hairy cell leukaemia with unusual BRAF mutations
• Hairy Cell Leukemia
• Hairy cell leukemia - etiopathogenesis, diagnosis and modern therapeutic approach
• Hairy Cell Leukemia (HCL) Presenting As Severe Acute Respiratory Distress Syndrome (ARDS) With Legionella pneumophila: Coincidence or Causation?
• Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies
• Hairy cell leukemia presenting as a pleural mass without leukemic component: a case report
• Hairy cell leukemia variant and WHO classification correspondence Re: 5(th) edition WHO classification haematolymphoid tumors: lymphoid neoplasms
• Hairy cell leukemia with isolated bone lesions
• Hairy cell leukemia with plasmacytoid morphology
• Hairy Cell Leukemia: Hematological and Immunophenotypic Profile of 13 Patients
• Hairy Cell Leukemia: Hepatic Affinity Status Post Splenectomy
• Hairy Cell Leukemia: Where Are We in 2023?
• Hairy gene homolog increases nasopharyngeal carcinoma cell stemness by upregulating <em>Bmi-1</em>
• Hairy gene homolog increases nasopharyngeal carcinoma cell stemness by upregulating Bmi-1
• HES1 is required for mouse fetal hematopoiesis
• Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH
• Interferon-Induced Retinopathy
• It's time to change the standard of care for hairy cell leukemia?!
• Leukemia Cutis
• Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study
• Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University
• Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
• Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study
• Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research Network
• Lymphoproliferative Disorders
• Maculopapular rash with multiple drug hypersensitivity to cotrimoxazole, amikacin, piperacillin/tazobactam, and meropenem in a patient with hairy cell leukemia
• MLL1 inhibits the neurogenic potential of SCAPs by interacting with WDR5 and repressing HES1
• Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets
• Mycobacterial spindle cell pseudotumor mimicking Richter transformation in a patient with hairy cell leukemia
• New Targeted Therapy Combination Holds Promise to Untangle Hairy Cell Leukemia
• Non-nodal mantle cell lymphoma mimicking hairy cell leukemia
• Non-V600E BRAF mutation in hairy cell leukemia variant
• Novel BRAF N581S mutation in mantle cell lymphoma
• Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma
• Phenolic compounds as potential adenosine deaminase inhibitors: molecular docking and dynamics simulation coupled with MM-GBSA calculations
• Plasma cell leukemia mimicking erstwhile hairy cell leukemia variant: A case with an intriguing immunophenotype
• Purpuric Eruption in a Patient With Hairy Cell Leukemia
• Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study
• Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group
• Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review
• Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report
• Simultaneous Purification of Human Interferon Alpha-2b and Serum Albumin Using Bioprivileged Fluorinated Ionic Liquid-Based Aqueous Biphasic Systems
• Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience
• Single-agent rituximab is an effective salvage therapy in pretreated hairy cell leukemia patients
• Single-agent rituximab is an effective salvage therapy in pretreated patients with hairy cell leukemia
• Single-center study of outcomes of patients with hairy cell leukemia who contracted SARS-CoV-2
• Splenic B-cell lymphoma/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature
• Targeting the BRAF pathway in haematological diseases
• The course of patients with hairy cell leukemia during the omicron surge of the Covid-19 pandemic
• The fifth edition of the WHO classification of mature B-cell neoplasms: open questions for research
• The Impact of Anemia on the Survival of Patients Diagnosed With Low-Grade Malignant B-cell Lymphomas
• The many faces of nodal and splenic marginal zone lymphomas
• The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop
• The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders
• The value of CD200 in differential diagnosis of classic hairy cell leukemia and variant hairy cell leukemia
• Therapy with mosunetuzumab, a bispecific antibody for relapsed/refractory hairy cell leukemia
• Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000-2018
• U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review)
• Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment
• Untangling the Strands of Hairy Cell Leukemia: The Clinicopathological Spectrum over Eleven Years at a Tertiary Care Center
• Unusual Clinical Presentations of Hairy Cell Leukemia
• Unusual presentation of gastric cancer during treatment of hairy cell leukemia: Exploring the etiological basis of this rare phenomenon
• Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia